Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/216402
Deletion of RGD-motif from penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Oncolytic viruses often face challenges in achieving optimal antitumor immunity as standalone therapies. The penton base RGD-integrin interactions play a significant fi cant role in wild-type adenovirus-induced innate immune responses. To modify these responses, we present ISC301, a novel oncolytic adenovirus engineered by deleting the natural RGD motifs in the penton base while incorporating artificial fi cial RGD motifs in the fi ber knobs. ISC301 demonstrated comparable in vitro infectivity, cytotoxic effects, and signaling profiles fi les across various cell types to its parental ICOVIR-5, which retains the penton base RGD motif. In immunodeficient fi cient and immunocompetent mouse models, ISC301 exhibited similar in vivo antitumor efficacy fi cacy to ICOVIR-5. However, ISC301 induced higher intratumoral inflammation fl ammation through NF-KB K B activation, leading to increased levels of tumor-infiltrating fi ltrating leukocytes and higher proportion of cytotoxic CD8+ + T cells. In addition, ISC301 elicits a heightened pro-inflammatory fl ammatory response in peripheral blood. Importantly, when combined with CAR T cell therapy, ISC301 exhibited superior antitumor efficacy, fi cacy, surpassing monotherapy outcomes. These fi ndings emphasize the impact of adenoviral modifications fi cations on antitumor immune responses. The deletion of penton base RGD motifs enhances ISC301's ' s pro-inflammatory fl ammatory profile fi le and boosts CART cell therapy efficacy. fi cacy. This study enhances understanding of oncolytic virus engineering strategies, positioning ISC301 as a promising candidate for combined immunotherapeutic approaches in cancer treatment.
Matèries
Matèries (anglès)
Citació
Citació
MORALES MOLINA, Alvaro, RODRIGUEZ MILLA, Miguel angel, GARCIA RODRIGUEZ, Patricia, HIDALGO, Laura, ALEMANY, Ramon, GARCIA CASTRO, Javier. Deletion of RGD-motif from penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy. _Molecular Therapy: Oncology_. 2024. Vol. 32, núm. 3, pàgs. 200863. [consulta: 20 de gener de 2026]. ISSN: 2950-3299. [Disponible a: https://hdl.handle.net/2445/216402]